“PATHOLOGICAL OUTCOME OF HER2 NEU-POSITIVE EARLY BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY”. Frontier in Medical and Health Research 3, no. 7 (September 2, 2025): 1552–1558. Accessed August 12, 2026. https://fmhr.net/index.php/fmhr/article/view/1887.